pharma · Persistent Corneal Epithelial Defect (PCED) · Recent onset Type 1 Diabetes
Doppel Farmaceutici
Dompe' Farmaceutici S.p.A.
Doppel Farmaceutici patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Via Martiri delle Foibe 1, Cortemaggiore (PC), Emilia-Romagna 29016, IT, napoli
- Founded
- 1994
- Employees
- 393
- Programs
- 11
- Drugs
- 14
- Patents
- 0
Doppel Farmaceutici patents
0 pharmaceutical patents indexed for Doppel Farmaceutici. 0 expire within 24 months.
Doppel Farmaceutici has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Doppel Farmaceutici have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Doppel Farmaceutici patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.